2016-06-30 |
135 |
|
alleging infringement of U .S . Patent Nos.
7,439,241 1 (the '" 241 patent"), 8,410,1022 (the …"'249 patent")
(collectively, "patents-in-suit"). The patents-in-suit claim compounds… '241 patent is invalid for obviousness type double
patenting over the '410 patent, which Plaintiffs…the '" 102 patent"), 8,426,410 3 ("the "'410 patent"),
8,859,551 4 (the…the "' 551 patent"), 8,513 ,247 5 (the '" 247 patent"), and 8,513,249 6 (the |
External link to document |
2016-09-15 |
182 |
|
Regarding Actavis's Infringement of U.S. Patent Nos. 7,439,241, 8,426,410, 8,513,247, and 8,513,249 filed…2015
5 January 2017
1:15-cv-00232-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2016-10-24 |
186 |
|
., Ph.D. Regarding the Validity of U.S. Patent Nos. 7,439,241, 8,426,410, 8,513,247, and 8,513, 249; and…2015
5 January 2017
1:15-cv-00232-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2016-11-15 |
194 |
|
Regarding Actavis's Infringement of U.S. Patent Nos. 7,439,241, 8,426,410, 8,513,247, and 8,513,249 filed…2015
5 January 2017
1:15-cv-00232-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2016-12-30 |
218 |
|
Proposed] Order of Dismissal as to U.S. Patent Nos. 8,410,102 and 8,859,551 by Galderma Laboratories …2015
5 January 2017
1:15-cv-00232-LPS
Patent
None
District Court, D. Delaware |
External link to document |